A. Houlton

发表

OPL091 Continuing prior antihypertensive medication in acute stroke lowers blood pressure: Data from the continue vs stop arm of the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial

J. Wardlaw, N. Sprigg, Stuart J. Pocock, 2005, Journal of the Neurological Sciences.

Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial.

A. Mead, C. Yap, A. Dueck, 2017, Blood.

Ruxolitinib versus best available therapy for ET intolerant or resistant to hydroxycarbamide in a randomized trial.

A. Mead, C. Yap, A. Dueck, 2022, Blood.

Prognostic value of monitoring a candidate immunophenotypic leukemic stem/progenitor cell population in patients allografted for acute myeloid leukemia

P. Vyas, C. Bradbury, C. Craddock, 2014, Leukemia.

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

P. Vyas, C. Craddock, S. Siddique, 2017, Clinical Cancer Research.

PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer

M. Jit, J. Chisholm, J. Bate, 2018, Archives of Disease in Childhood.

Statistical analysis plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) trial

S. Pocock, J. Wardlaw, P. Bath, 2014, International journal of stroke : official journal of the International Stroke Society.

Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

Jennifer L Becker, Joanna M Wardlaw, Robert A Dineen, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer: Results From a Prospective Longitudinal Feasibility Study

S. Kehoe, Kavita Singh, S. Sundar, 2015, International Journal of Gynecologic Cancer.

A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL

S. Barrans, A. Pettitt, M. Roudier, 2019, Hematological oncology.

The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours: protocol for a systematic review and meta-analysis

B. Phillips, P. Kearns, C. Main, 2015, Systematic Reviews.

University The role of high-dose myeloablative chemotherapy with haematopoietic stem cell transplantation (HSCT) in children with central nervous system (CNS) tumours

B. Phillips, P. Kearns, K. Wheatley, 2015 .

Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial

J. Wardlaw, L. Cala, A. Adami, 2015, Journal of Neurology, Neurosurgery & Psychiatry.

RUXOLITINIB COMPARED WITH BEST AVAILABLE THERAPY FOR ESSENTIAL THROMBOCYTHAEMIA PATIENTS RESISTANT OR INTOLERANT TO HYDROXYCARBAMIDE IN MAJIC - AN INVESTIGATOR LEAD RANDOMIZED TRIAL

A. Mead, C. Yap, A. Dueck, 2016 .